Charting the "Splice" Routes to MDS.

Abstract excerpt

Mutations in components of the 3' mRNA splicing machinery are found in almost 50% of myelodysplastic syndrome (MDS) cases. In this issue of Cancer Cell, Kim and colleagues, Colla and colleagues, and Shirai and colleagues report on the impact of mutated or dysregulated splicing factors to hematopoiesis, mRNA splicing, and MDS pathogenesis.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cell Differentiation
• Share to Hematopoiesis
• Share to Myelodysplastic Syndromes